Apeloa Pharmaceutical Co.,Ltd (SHE: 000739)
China
· Delayed Price · Currency is CNY
16.32
-0.34 (-2.04%)
Nov 15, 2024, 3:04 PM CST
Apeloa Pharmaceutical Co.,Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 1,074 | 1,055 | 989.17 | 955.55 | 816.73 | 553.4 | Upgrade
|
Depreciation & Amortization | 552.9 | 552.9 | 389.43 | 358.64 | 344.06 | 353.55 | Upgrade
|
Other Amortization | 6.08 | 6.08 | 5.18 | 3.92 | 4.53 | 3.31 | Upgrade
|
Loss (Gain) From Sale of Assets | -1.33 | -1.33 | -1.37 | -0.28 | -8.52 | -4.23 | Upgrade
|
Asset Writedown & Restructuring Costs | 7.79 | 7.79 | 4.67 | 55.84 | 43.74 | 19.37 | Upgrade
|
Loss (Gain) From Sale of Investments | 18.08 | 18.08 | 82.61 | -66.73 | -109.46 | 16.87 | Upgrade
|
Provision & Write-off of Bad Debts | 1.92 | 1.92 | 12.71 | - | - | -0.59 | Upgrade
|
Other Operating Activities | 463.72 | 164.86 | 12.27 | -13.57 | 42.58 | 57.67 | Upgrade
|
Change in Accounts Receivable | -571.63 | -571.63 | -1,108 | -851.44 | -176.76 | -294.39 | Upgrade
|
Change in Inventory | -373.35 | -373.35 | -603.07 | -190.08 | -116.91 | -124.9 | Upgrade
|
Change in Accounts Payable | 130.17 | 130.17 | 1,649 | 373.38 | 201.09 | 787.79 | Upgrade
|
Change in Other Net Operating Assets | 36.87 | 36.87 | -2.74 | 0.5 | - | - | Upgrade
|
Operating Cash Flow | 1,349 | 1,031 | 1,326 | 611.75 | 1,060 | 1,360 | Upgrade
|
Operating Cash Flow Growth | 3.42% | -22.23% | 116.77% | -42.26% | -22.10% | 63.31% | Upgrade
|
Capital Expenditures | -584.24 | -630.47 | -509.11 | -701.92 | -317.12 | -31.85 | Upgrade
|
Sale of Property, Plant & Equipment | 10.99 | 8.96 | 4.87 | 3.88 | 16.68 | 6.59 | Upgrade
|
Cash Acquisitions | - | - | - | - | - | -0.98 | Upgrade
|
Divestitures | 7.6 | 30.4 | - | - | - | - | Upgrade
|
Investment in Securities | 4.31 | -77.9 | -5.78 | 92.56 | 382.63 | -358.6 | Upgrade
|
Other Investing Activities | -19.19 | -7.79 | -81.29 | 90.1 | 24.17 | -56 | Upgrade
|
Investing Cash Flow | -580.53 | -676.8 | -591.3 | -515.39 | 106.37 | -440.84 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | - | 380 | Upgrade
|
Long-Term Debt Issued | - | 1,061 | 1,085 | 805.16 | 484.1 | - | Upgrade
|
Total Debt Issued | 1,041 | 1,061 | 1,085 | 805.16 | 484.1 | 380 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | - | -944.1 | Upgrade
|
Long-Term Debt Repaid | - | -980.02 | -725.88 | -707.57 | -204 | - | Upgrade
|
Total Debt Repaid | -1,005 | -980.02 | -725.88 | -707.57 | -204 | -944.1 | Upgrade
|
Net Debt Issued (Repaid) | 36.52 | 81.16 | 359.57 | 97.59 | 280.1 | -564.1 | Upgrade
|
Repurchase of Common Stock | - | - | -200.2 | - | - | - | Upgrade
|
Common Dividends Paid | -407.81 | -383.02 | -362.8 | -301.92 | -201.35 | -142.05 | Upgrade
|
Other Financing Activities | -153.39 | 0.38 | 7.35 | - | - | - | Upgrade
|
Financing Cash Flow | -524.68 | -301.48 | -196.09 | -204.32 | 78.75 | -706.15 | Upgrade
|
Foreign Exchange Rate Adjustments | -3.23 | 27.49 | 44.04 | -17.32 | -38.28 | 3.27 | Upgrade
|
Net Cash Flow | 240.09 | 80.57 | 582.76 | -125.29 | 1,206 | 216.35 | Upgrade
|
Free Cash Flow | 764.29 | 400.9 | 817 | -90.18 | 742.41 | 1,328 | Upgrade
|
Free Cash Flow Growth | -2.51% | -50.93% | - | - | -44.10% | 76.81% | Upgrade
|
Free Cash Flow Margin | 6.23% | 3.49% | 7.75% | -1.01% | 9.42% | 18.42% | Upgrade
|
Free Cash Flow Per Share | 0.66 | 0.34 | 0.70 | -0.08 | 0.63 | 1.13 | Upgrade
|
Cash Income Tax Paid | 1.56 | -2.88 | -41.97 | 149.94 | -93.46 | 128.18 | Upgrade
|
Levered Free Cash Flow | 450.29 | -28.58 | 1,366 | 554.62 | 442.19 | 1,578 | Upgrade
|
Unlevered Free Cash Flow | 474.61 | -1.23 | 1,403 | 576.94 | 452.2 | 1,597 | Upgrade
|
Change in Net Working Capital | 210.73 | 603.38 | -950.6 | -316.69 | 94.02 | -894.79 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.